Nusano
  • Home
  • Company
    • Leadership
    • West Valley City
  • Technology
  • News
  • Careers
  • Contact Us
Select Page
Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

by Scott Larrivee | May 15, 2023 | News, Utah

SALT LAKE CITY and BOCA RATON, Fla. – May 15, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, and PharmaLogic, a world-class contract development and manufacturing organization (CDMO) specializing in radiopharmaceuticals,...
Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian

Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian

by Scott Larrivee | May 11, 2023 | News

VALENCIA, Calif. and WEST VALLEY CITY, Utah – May 11, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it is creating an in-house stable isotope program to enhance the company’s medical radioisotope production...
Nusano to Participate in the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day

Nusano to Participate in the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day

by Scott Larrivee | May 9, 2023 | News

NEW YORK – May 9, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will participate in a fireside chat at the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day in New York City on Monday, May 15,...
Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals

Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals

by Scott Larrivee | May 4, 2023 | News

Virtual event will take place on Friday, May 12, 2023 at 10 a.m. EST Register NEW YORK – May 4, 2023 – Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, today announced it will host a virtual Key Opinion Leader (KOL) event on Friday,...
Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

by Scott Larrivee | May 1, 2023 | News

Proprietary ion source and beam technology capable of producing approximately 10 times the current global supply of Astatine-211 Updated May 4, 2023 to add presentation materials Download PDF PRESENTATION The Nusano Medical Radioisotope Production Platform: Supplying...
« Older Entries

Recent Posts

  • Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
  • Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian
  • Nusano to Participate in the 2nd Annual Guggenheim Securities Radiopharmaceuticals Day
  • Nusano to Host Key Opinion Leader Webinar on Isotope Production and Applications for Oncology Radio-pharmaceuticals
  • Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group

Recent Comments

No comments to show.
Supplying the fight against cancer.
  • Follow
Company
about us
Leadership
Contact us
technology
Proprietary tech
Applications
Investors
Resources
News
Careers
Suppliers
© 2023 Nusano | Web design
Privacy Policy – Terms of Service